z-logo
open-access-imgOpen Access
CD271+ Mesenchymal Stem Cells as a Possible Infectious Niche for Leishmania infantum
Author(s) -
Carolina Salomão Lopes,
Nada Daifalla,
Bikul Das,
Valdo Dias da Silva,
Antonio CamposNeto
Publication year - 2016
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0162927
Subject(s) - leishmania infantum , mesenchymal stem cell , visceral leishmaniasis , leishmania donovani , leishmaniasis , leishmania , biology , bone marrow , immunology , virology , parasite hosting , microbiology and biotechnology , world wide web , computer science
Visceral leishmaniasis (VL) is a serious and fatal disease. Therapeutic drugs are toxic and non-sterilizing. The etiological agents Leishmania infantum and Leishmania donovani cause active and asymptomatic diseases. Effective drugs to treat VL exist but unfortunately, post-treatment relapses are common. Little is known why drugs are non-sterilizing or how these intracellular pathogens can escape treatment. Here, using a murine model of VL we found that CD271+/Sca1+ bone marrow mesenchymal stem cells (BM-MSCs) are readily infected in vitro and in vivo by L . infantum . Because BM-MSCs express potent drug efflux pumps, e.g., ABCG2 it is possible that this unique intracellular infectious niche could allow L . infantum to escape anti-parasite drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom